GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

alemtuzumab   Click here for help

GtoPdb Ligand ID: 6770

Synonyms: campath 1H | Campath® | campath-1H | Lemtrada®
Approved drug Immunopharmacology Ligand
alemtuzumab is an approved drug (FDA (2001), EMA (2013))
Compound class: Antibody
Comment: CAMPATH-1 (CD52) antigen inhibitor. Functionally, alemtuzumab causes depletion and then recovery of the immune system.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: alemtuzumab

Immunopharmacology Disease
Disease X-Refs Comment References
Relapsing-remitting multiple sclerosis Disease Ontology: DOID:2378
 Approved drug for RR-MS, and controlled access for B-cell chronic lymphocytic leukemia (CLL) and transplant indications.